Subcutaneous versus intravenous fentanyl for labor pain management: A multicenter randomized controlled trial

Phase 4

• Conditions: Pregnant women who plan vaginal delivery and have labor pain at 37-41+6 weeks of gestation; fentanyl, labor pain reduction

• Registration Number: TCTR20220215009
• Lead Sponsor: Khon Kaen University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-02-15
• Study Completion: 2023-03-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: nknown
• Sex: Female
• Target Recruitment: 226

Inclusion Criteria

1.pregnant women who 18 years old or older
2. gestational age between 37 - 41 weeks 6 days
2. plan vaginal delivery
3. singleton pregnancy with cephalic presentation
4. no obstetric or medical complication
5. require medication for labor pain relief
6. cervix open 4-9cm.

Exclusion Criteria

1. pregnant women who have fetal anomaly
2. pregnant women who receive pethidine or morphine 24 hour prior
3. pregnant women who addict opioid drugs
4. pregnant women who receive any psychosis drugs 14 days prior admission
5. pregnant women who have epilepsy and on enzyme CYP 3A4 inducers drugs such as carbamazepine, phenytoin ,rifampin
6. pregnant women who have underlying disease such as liver disease heart disease respiratory tract infection
7. pregnant women who do not understand Thai language

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain score multiple Numeric pain scale measurement

Secondary Outcome Measures

Name	Time	Method
Sactisfaction single questionaire